Home/Filings/4/0001235802-20-000122
4//SEC Filing

Kellen Scott 4

Accession 0001235802-20-000122

CIK 0001401040other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 8:16 AM ET

Size

5.2 KB

Accession

0001235802-20-000122

Insider Transaction Report

Form 4
Period: 2020-11-09
Kellen Scott
CFO & Secretary
Transactions
  • Purchase

    Voting Common Shares, no par value per share

    2020-11-09$4.19/sh+2,000$8,38712,290 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.1824 to $4.21, inclusive. The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Issuer

DiaMedica Therapeutics Inc.

CIK 0001401040

Entity typeother

Related Parties

1
  • filerCIK 0001490476

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 8:16 AM ET
Size
5.2 KB